You can buy or sell SRPT and other stocks, options, ETFs, and crypto commission-free!
Sarepta Therapeutics, Inc. Common Stock (DE), also called Sarepta Therapeutics, is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. Read More The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
Yahoo FinanceMar 14
Sarepta or Amarin: Who Is Controlling Expenses Better?
Sarepta and Amarin: How These Biotech Stocks Stack Up(Continued from Prior Part)Growth catalysts In its fourth-quarter earnings conference call, Sarepta Therapeutics (SRPT) highlighted its submission of an NDA (new drug application) in the fourth...
Yahoo FinanceMar 13
Sarepta and Amarin: What to Expect from Their EPS Growth
Sarepta and Amarin: How These Biotech Stocks Stack Up(Continued from Prior Part)Growth trends In its fourth-quarter earnings conference call, Sarepta Therapeutics (SRPT) reported Exondys sales of around $301 million, a YoY rise of around 98%. In...
Simply Wall StMar 13
If You Had Bought Sarepta Therapeutics (NASDAQ:SRPT) Shares Three Years Ago You’d Have Made 822%
We think that it’s fair to say that the possibility of finding fantastic multi-year winners is what motivates many investors. Not every pick can be a winner, but when you pick the right stock, you can win big. For example, the Sarepta Therapeutics, Inc. (NASDAQ:SRPT) share price is up a whopping 822% in the last three years, a handsome return for long term holders. In the last week the share price is up 1.4%. Anyone who held for that rewarding ride would probably be keen to talk about it. See our latest a...
Expected May 2, After Hours